Exodus Point Capital Management, LP Axonics, Inc. Transaction History

Exodus Point Capital Management, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$48.64 - $62.51 $287,121 - $368,996	-5,903 Reduced 36.44%	10,298 $578,000
Q2 2023 Aug 10, 2023	SELL	$47.99 - $60.21 $1.34 Million - $1.69 Million	-28,021 Reduced 63.36%	16,201 $818,000
Q1 2023 May 11, 2023	BUY	$52.6 - $67.34 $356,838 - $456,834	6,784 Added 18.12%	44,222 $2.41 Million
Q4 2022 Feb 13, 2023	BUY	$59.56 - $76.6 $1.66 Million - $2.13 Million	27,836 Added 289.9%	37,438 $2.34 Million
Q3 2022 Nov 10, 2022	SELL	$57.96 - $78.12 $446,060 - $601,211	-7,696 Reduced 44.49%	9,602 $676,000
Q2 2022 Aug 19, 2022	BUY	$39.5 - $64.42 $683,271 - $1.11 Million	17,298 New	17,298 $980,000
Q1 2021 May 17, 2021	SELL	$49.14 - $59.89 $14,250 - $17,368	-290 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$42.19 - $51.5 $12,235 - $14,935	290 New	290 $14,000
Q3 2019 Nov 14, 2019	SELL	$26.92 - $42.41 $1.4 Million - $2.21 Million	-52,108 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$18.54 - $40.97 $966,082 - $2.13 Million	52,108 New	52,108 $2.14 Million

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.